Lupin gets USFDA to market generic anti-fungal cream in US market

Drug maker Lupin on Tuesday said it has received approval from the US health regulator to market Tavaborole Topical solution, an antifungal medication. The company has received approval from the US Food and Drug Administration (USFDA) to market its product, which is a generic version of Anacor Pharmaceuticals' Kerydin Topical Solution, Lupin said in a statement.
Read more...

;